Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,377 | -5,259 | -8,281 | -16,312 | -12,036 |
| Depreciation Amortization | 505 | 201 | 380 | 24 | 12 |
| Income taxes - deferred | N/A | N/A | 116 | 865 | 824 |
| Accounts receivable | N/A | N/A | 229 | -614 | -121 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -23 |
| Other Working Capital | -615 | -408 | 491 | 636 | -1,614 |
| Other Operating Activity | 5,501 | 3,657 | 2,879 | 8,004 | 5,360 |
| Operating Cash Flow | $-2,986 | $-1,809 | $-4,187 | $-7,398 | $-7,598 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -21 | -120 | -18 |
| Purchase Of Investment | N/A | N/A | -339 | -1,602 | -789 |
| Other Investing Activity | -1,209 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,209 | $0 | $-360 | $-1,722 | $-806 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 30 | N/A | 350 | 4 |
| Debt Issued | 889 | 942 | 1,463 | N/A | 237 |
| Debt Repayment | -427 | -327 | N/A | N/A | -307 |
| Common Stock Issued | 4,297 | 1,373 | 3,456 | 3,664 | 11,120 |
| Common Stock Repurchased | N/A | -7 | N/A | N/A | N/A |
| Other Financing Activity | -120 | -29 | -1,049 | 0 | -1,058 |
| Financing Cash Flow | $4,638 | $1,981 | $3,870 | $4,014 | $9,996 |
| Exchange Rate Effect | 20 | -25 | 2 | -67 | -28 |
| Beginning Cash Position | 864 | 717 | 1,392 | 6,565 | 5,001 |
| End Cash Position | 1,327 | 864 | 717 | 1,392 | 6,565 |
| Net Cash Flow | $463 | $147 | $-675 | $-5,174 | $1,564 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,986 | -1,809 | -4,187 | -7,398 | -7,598 |
| Capital Expenditure | N/A | N/A | -21 | -120 | -18 |
| Free Cash Flow | -2,986 | -1,809 | -4,208 | -7,518 | -7,615 |